Navigation Links
At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed)

y Rat Neurons by a GABA-Independent Pathway in presentation P-192. About Neurochem

Neurochem Inc. is focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs. Eprodisate (KIACTA(TM)) is currently being developed for the treatment of Amyloid A (AA) amyloidosis, and is under regulatory review for marketing approval by the United States Food and Drug Administration, European Medicines Agency and Swissmedic. Tramiprosate (ALZHEMED(TM)), for the treatment of Alzheimer's disease, has completed a Phase III clinical trial in North America and is currently in a Phase III clinical trial in Europe, while tramiprosate (CEREBRIL(TM)), for the prevention of Hemorrhagic Stroke caused by Cerebral Amyloid Angiopathy, has completed a Phase IIa clinical trial.

To Contact Neurochem

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1 877 680-4500 or visit our Web Site at: www.neurochem.com.

This news release contains forward-looking statements regarding tramiprosate (ALZHEMED(TM)) as well as regarding continuing and further development efforts. These statements are based on the current analysis and expectations of management. Drug development necessarily involves numerous risks and uncertainties, which could cause actual results to differ materially from this current analysis and these expectations. Analysis regarding the results of clinical trials may not provide definitive results regarding safety, tolerability or therapeutic benefits. Even if all the endpoints sought in the clinical trials were met (which is not certain), there is no certainty that regulators would ultimately approve tramiprosate (ALZHEMED(TM)) for sale to the public. Risks and uncertainties may include: failure to demonstrate the safety, tolerability and efficacy of our product, that ac
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
6. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
7. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
8. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
9. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
10. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
11. Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimers Drug
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014  Decision Resources ... brought about by the Affordable Care Act ... prescribing of pharmaceutical therapies. The ACA altered ... through new regulations and expanded access via ... the health exchanges—state-based marketplaces set up by ...
(Date:7/31/2014)... , July 31, 2014 Touro University California,s ... been selected as the recipient of a $150,000 grant ... allow the University to increase research and classroom space ... state-of-the-art technology for the study of health sciences, and ... diverse needs and interests of our students," said ...
(Date:7/31/2014)... 31, 2014 For its innovative modular Biomedical ... , Art,s-Way Scientific has earned a Modular Building Institute ... in over 30 categories, MBI,s contest is the commercial ... include building manufacturers, dealers, and product and service providers. ... the capability of our team," said Dan Palmer ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... Institute, the leading provider of specialized training solutions ... subsidiary of Campbell Alliance, announced today the completion ... Area Essentials™ e-course series.  This series ... biotech R&D and commercial professionals.  It includes 155 ...
... Calif., June 20, 2011 Inogen has been honored ... the Inogen One Portable Oxygen Concentrator.  The Medical Design ... exclusively recognizes contributions and advances in the design of ... by Goleta, California based Inogen, Inc. is used to ...
Cached Medicine Technology:Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma 2Inogen One Wins Gold Medical Design Excellence Award 2
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, ... West Africa has a well-earned reputation as one of the ... and intense medical care can greatly improve a person,s chances ... which wreaks life-threatening havoc within the body by attacking multiple ... fall back on the basics of "good meticulous intensive care," ...
(Date:8/1/2014)... New research shows that people who grew up in ... 16-percent greater risk of experiencing poor health quality than ... to prison. The finding, which accounted for other forms ... of imprisonment may be independently imparting enduring physical and ... were children when this happened, and it was a ...
(Date:8/1/2014)... August 01, 2014 Did you know that ... Sarcoma Awareness Month is to raise awareness across the country ... options for, sarcoma. According to the American Cancer Society, nearly ... 2014, while 12,000 new soft tissue sarcomas will be diagnosed. ... sarcoma tumors as they are other kinds of cancer,” said ...
(Date:8/1/2014)... Seattle, Wa (PRWEB) August 01, 2014 According ... Vkool.com, this is a comprehensive diet guide for women who ... discover a list of protein rich foods and ... keeping lean muscle mass. , Vkool writes in its review ... to readers the truth about fat burning hormones and weight ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Blindness is ... argued that the scientists of today, despite well-meaning efforts, still ... providing a definite treatment for reversing blindness that does not ... sense, this is where alternative medicine takes the “slack” from ... on expensive treatments or harmful surgeries. , Alternative health ...
Breaking Medicine News(10 mins):Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 3Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:July Was Sarcoma Awareness Month! 2Health News:July Was Sarcoma Awareness Month! 3Health News:July Was Sarcoma Awareness Month! 4Health News:The Metabolic Switch Diet PDF Review Exposes Sally Asher's Diet Guide For Boosting Metabolism – Vkool.com 2Health News:The Metabolic Switch Diet PDF Review Exposes Sally Asher's Diet Guide For Boosting Metabolism – Vkool.com 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2
... breast conservation surgery is the most common type of ... surgery is that only part of the breast is ... appearance of the breast, which may be disfigured, dented ... Surgery, the official medical journal of the American Society ...
... Business Alliance will help to raise funds and ... Logistics, an industry leader,focused on single-source supply chain ... K2 Logistics, headquartered in Eagan, announced,today its K2 ... (PAM) Team. Also joining in the fight against ...
... 90th Annual MeetingENDO 08will be held at the Moscone ... , Reporters can register here: http://www.endo-society.org/media/ENDO-08/ ... the world are expected to assemble for this premier ... , It is the opportunity for journalists to learn ...
... from 11 to 17 years of age smoke. This ... and Examination Survey for Children and Adolescents (KiGGS), performed ... sociologist Thomas Lampert in the current edition of Deutsches ... The analysis of tobacco consumption by children and adolescents ...
... International,Inc. (Nasdaq: CHDX ) a leading independent ... the People,s Republic of China, today,announced that Roberta ... following investment conferences in New York City:, ... being held,from May 19-20, 2008 at The Waldorf ...
... Offerings Thus ... Far, ... health care system or state legislation,mandating coverage. Instead, they prefer relying on ... and the National Business Group on Health., More than three-quarters (84 ...
Cached Medicine News:Health News:Breast reconstruction advances fix distortions left by lumpectomy 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 2Health News:K2 Logistics & Strategic Warehousing Join The Parkinson Association of Minnesota (PAM) Team! 3Health News:ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 3Health News:Most Companies Oppose Single-Payer Health Care System, State Coverage Mandates 2
... The Forceps Are Available In Two Models: ... Are Compressed, The Jaws Close. The Other ... The Handles Are Compressed The Jaws Open., ,The ... To Be Inserted Through A 1.1mm Incision. These ...
... Turned 90 Degrees To Allow Full ... Incising Tissue. ,Special Mirror-Polished Double Footplate Construction ... Extension Settings Of 0.5mm, 0.55mm, 0.6mm, ... Wide Snub Nose Diamond Blade Is ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
2.5V Halogen source, fiber-optic delivery, 3X magnification, pocket-sized....
Medicine Products: